#gynonc at @OHSUKnight. Views are mine; no COIs.
Portland, OR
Joined November 2009
- Tweets2.4K
- Following759
- Followers1K
- Likes1.6K
Multicenter retrospective study of patients with early #cervicalcancer (n=675) finds assessment of tumor size by preoperative exam and/or MRI have good concordance (>80%) with surgical pathology measurements. #gyncsm @Pan_Teresa_MD @pedroramirezMD @IJGConline ijgc.bmj.com/content/early/2…
Randomized trial of patients with high-risk #endometrialcancer (n=1095) did not find improvement in disease-free survival from adding #pembrolizumab to postoperative adjuvant treatment (HR 1.02, 95% CI 0.79-1.32, p=.57). Pembrolizumab was associated with better survival (HR 0.31, 95% CI 0.14-0.69) for patients with MMR deficient tumors (n=281). #gyncsm @Annals_Oncology annalsofoncology.org/article…
Ross Harrison, MD MPH retweeted
Today at the @RivkinCenter AACR Ovarian Cancer Research Symposium Moffitt’s Karen Lu, MD (@karenluMD) co-chairs the Prevention, Early Detection, & Interception session. Check out her video to learn more!
⏰: 9/20 -4:50 p.m. PDT
📍: Washington Ballroom
Learn more ➡️ bit.ly/47E4WlK
Ross Harrison, MD MPH retweeted
Excited to represent @SGO_org @GYNCancer as Social Media Ambassador for our 2025 Annual #SGOMtg! ⏰ Abstract submission deadline is approaching quickly Sept 27th! We will Multiply Your Impact through our exciting program and social media!💥Join us in Seattle! #AM25IMPACT #gyncsm
Remember the incredible abstracts presented at the SGO 2024 Annual Meeting on Women’s Cancer?
If you're interested in presenting in 2025, SGO is now accepting abstract and surgical film submissions for the 2025 Annual Meeting. #SGOMtg #AM25IMPACT
Submit: sgo.org/events/annual-meetin…
Surgical video reviewing uterine transposition, patient selection, & postoperative management.👏👏👏 #crcsm #ayacsm #gynonc #gyncsm @leitaomd @JennyMueller_ @MSKCancerCenter @AnnSurgOncol link.springer.com/article/10…
Ross Harrison, MD MPH retweeted
People with advanced #EndometrialCancer now have new FDA-approved treatment options: pembrolizumab and durvalumab, paired with chemotherapy, for tumors with a genetic change called mismatch repair deficiency. go.nih.gov/Qmz5ojG
ALT A depiction of immune cells attacking cancer cells.
Nice presentation of FIGO 2023 #endometrialcancer staging. From a review in @NatRevClinOncol. @jahow514 nature.com/articles/s41571-0…
Ross Harrison, MD MPH retweeted
Rates of new #UterineCancer cases increased by 0.7% each year from 2012 to 2021. The death rate from uterine cancer increased by 1.5% each year from 2013 to 2022. Visit our Cancer Stat Facts sheet to learn more: buff.ly/2YXE2S4 #GynCSM
Ross Harrison, MD MPH retweeted
From medical enigma to a roadmap for recovery, one @OHSUNews patient's life-altering journey through a rare skin, musculature condition and stage 3 cancer.
This is Kathy's remarkable story: bit.ly/4b2Exhx
Ross Harrison, MD MPH retweeted
#Small bite fascial closure reduces #incisional hernia rates in #GynOncology patients by @uppals @astraubhar
📄 bit.ly/45hpH5D
@umichMedicine @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4
Dr. Frumovitz has made an incredible impact in #gynonc, both as a gifted educator & researcher. Consider a gift to honor his contributions to our field & support his research in the treatment of rare #gyn cancers. mdanderson.donordrive.com/in… @Frumovitz @MDAndersonNews @SGO_org @IGCSociety @IJGConline @gynoncjnls #gyncsm
Ross Harrison, MD MPH retweeted
The rate of new #OvarianCancer cases fell by 2.7% each year from 2012 – 2021 and the death rate fell by 2.4% each year from 2013 – 2022. Visit our Cancer Stat Facts sheet to learn more: buff.ly/2ITyl21 #GynCSM #WorldOvarianCancerDay
Ross Harrison, MD MPH retweeted
Ever wonder why your insurer charges a copay for statins (and other high-value meds)?
Don’t they want to prevent heart attacks, strokes, etc?
Copays never made sense to me.
In this new paper in @QJEHarvard, we show copays kill. 🧵
tinyurl.com/nhk4v93f
Adding cisplatin to radiation doesn't improve progression-free survival for localized recurrent #endometrialcancer but does increase treatment-related toxicity. Radiation remains standard of care. ascopubs.org/doi/10.1200/JCO… @JCO_ASCO @AnnKloppMD @dsmgyo #gyncsm #gynonc
Ross Harrison, MD MPH retweeted
Dear members of @sgo, a question came up during our journal club and I cannot find the answer. Can someone please help?
Why did investigators in the RUBY trial pick 3 years of Dostarlimab maintenance? Is there a biologic explanation? @matthewapowell #endometrialcancer
Among patients undergoing gynecologic cancer surgery, adding metronidazole to cefazolin for antibiotic prophylaxis was associated with a reduced rate of surgical site infection. 👏👏👏 @AJOG_thegray sciencedirect.com/science/ar… @AnneKniselyMD @TaylorJolyn @kmschmeler @MDAndersonNews
Ross Harrison, MD MPH retweeted
So excited to be in Mozambique with @NCICastle collaborating with @CISPOC_DPCM @uemmoz and @MDAndersonNews team to launch the PHIL study - a randomized trial of LEEP vs. Thermal Ablation in WLWH @MilaPSalcedo @MelissaLoVaron @echiaomd @JoseAJeronimo #EndCancer
